Long-Term Stability and Safety of the Soundbridge Coupled to the Round Window.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
05 2021
Historique:
revised: 30 10 2020
received: 01 09 2020
accepted: 03 11 2020
pubmed: 20 11 2020
medline: 11 5 2021
entrez: 19 11 2020
Statut: ppublish

Résumé

The objective of the study was to demonstrate the long-term outcomes of patients implanted with the active middle ear implant (AMEI) Vibrant Soundbridge (VSB) through coupling the floating mass transducer (FMT) to the round window (RW). This retrospective study evaluated the short- and long-term clinical performance (audiological outcomes) and safety (revisions/explantations) of the VSB coupled to the RW between 2013 and 2019 at the St. Pölten University Hospital, Austria. For the outcome analysis, the sample was divided into a short-term examination group followed up for less than 12 months (<12 months) and a long-term examination group followed up for more than 12 months (>12 months). Cumulative survival outcomes were separately analyzed for subjects with and without cholesteatoma. 46 patients with an average long-term follow-up period of 31.43 months (13-75 months) were investigated. Complications requiring revision surgery were reported in total in seven patients with cholesteatoma (15.2%) and none in subjects without cholesteatoma (0%). Residual hearing was not affected by VSB surgery. Word understanding on the Freiburger monosyllabic speech test improved significantly at 65 dB (P < .0001) and 80 dB (P < .0001), and these outcomes were stable for long-term follow up. The VSB coupled to the RW is a safe implantation method for patients with conductive or mixed hearing loss. Hearing improvement was stable for the long-term follow-up up to 74 months. The revision rates are directly related to the underlying pathology of cholesteatoma (with radical cavity); thus, this special cohort requires additional counseling on potential complications. 4 (Case-series) Laryngoscope, 131:E1434-E1442, 2021.

Identifiants

pubmed: 33210744
doi: 10.1002/lary.29269
pmc: PMC8246711
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E1434-E1442

Informations de copyright

© 2020 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).

Références

Hear Res. 2017 Sep;353:97-103
pubmed: 28666703
Otol Neurotol. 2013 Jul;34(5):855-61
pubmed: 23739560
Adv Otorhinolaryngol. 2010;69:38-50
pubmed: 20610913
Adv Otorhinolaryngol. 2018;81:43-56
pubmed: 29794434
Ann Otol Rhinol Laryngol. 2014 Oct;123(10):734-40
pubmed: 24842869
Otol Neurotol. 2016 Mar;37(3):252-66
pubmed: 26796211
Laryngoscope. 2019 Feb;129(2):477-481
pubmed: 30284273
Otolaryngol Head Neck Surg. 2013 Jul;149(1):134-41
pubmed: 23585147
Otol Neurotol. 2006 Feb;27(2):183-8
pubmed: 16436987
Laryngorhinootologie. 2011 Sep;90(9):560-72
pubmed: 21913153
Otol Neurotol. 2016 Jun;37(5):513-9
pubmed: 27023016
Laryngoscope. 2016 Jun;126(6):1451-7
pubmed: 26468033
J Basic Clin Physiol Pharmacol. 2014 Sep;25(3):273-6
pubmed: 25046313

Auteurs

Georg Mathias Sprinzl (GM)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria.

Philipp Schoerg (P)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria.

Stefanie Muck (S)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.

Max Jesenko (M)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.

Sophie Speiser (S)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.

Marlene Ploder (M)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria.

Stefan Herwig Edlinger (SH)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria.

Astrid Magele (A)

Department of Otorhinolaryngology, Head & Neck Surgery, University Clinic St. Poelten, St. Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH